GH Research (GHRS) Assets Average (2021 - 2025)
GH Research's (GHRS) quarterly Assets Average came in at $295.1 million in Q4 2025, up 52.17% year-on-year from $193.9 million in Q4 2024, and down 4.09% quarter-over-quarter from $307.7 million in Q3 2025.
GH Research (GHRS) Assets Average (2021 - 2025) Analysis & Trends
GH Research's Assets Average history runs 5 years deep, the most recent figure standing at $295.1 million for Q4 2025.
- On a quarterly basis, Assets Average rose 52.17% year-over-year to $295.1 million in Q4 2025; TTM through Dec 2025 was $295.1 million, a 52.17% increase from a year earlier, with the FY2025 full-year figure at $238.3 million, up 14.94% from the prior year.
- Assets Average slipped to $295.1 million in Q4 2025 per GHRS's latest filing, from $307.7 million in the prior quarter.
- Across five years, Assets Average topped out at $316.9 million in Q2 2025 and bottomed at $193.9 million in Q4 2024.
- The 5-year median for Assets Average is $254.4 million (2025), against an average of $254.5 million.
- Across the five-year window, Assets Average fell 15.47% in 2024 and surged 52.17% in 2025, its largest moves.
- Year by year, Assets Average stood at $286.9 million in 2021, then slipped by 10.33% to $257.2 million in 2022, then declined by 10.81% to $229.4 million in 2023, then fell by 15.47% to $193.9 million in 2024, then jumped by 52.17% to $295.1 million in 2025.
- Per Business Quant, the three latest GHRS Assets Average figures stand at $295.1 million (Q4 2025), $307.7 million (Q3 2025), and $316.9 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | GH Research | 1.69 Bn | 1.69 Bn | - | 295.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 295.13 Mn |
| Sep 30, 2025 | 307.73 Mn |
| Jun 30, 2025 | 316.94 Mn |
| Mar 31, 2025 | 254.36 Mn |
| Dec 31, 2024 | 193.94 Mn |
| Sep 30, 2024 | 203.29 Mn |
| Jun 30, 2024 | 212.28 Mn |
| Mar 31, 2024 | 221.94 Mn |
| Dec 31, 2023 | 229.43 Mn |
| Sep 30, 2023 | 236.42 Mn |
| Jun 30, 2023 | 244.77 Mn |
| Mar 31, 2023 | 251.81 Mn |
| Dec 31, 2022 | 257.24 Mn |
| Sep 30, 2022 | 263.22 Mn |
| Jun 30, 2022 | 269.93 Mn |
| Mar 31, 2022 | 280.83 Mn |
| Dec 31, 2021 | 286.87 Mn |